With 64% institutional ownership, C4 Therapeutics, Inc. (NASDAQ:CCCC) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, C4 Therapeutics' stock price might be vulnerable to...

Related Keywords

,T Rowe Price Group Inc ,Therapeutics Inc ,Wasatch Advisors ,Rowe Price Group ,Soleus Capital Management ,